Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
ATOS holding history
Atossa Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATOS overviewAll 13F holders of ATOSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −4,853−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q4 2025 | 72,802 | $43.0K | <0.1% | −65,841−47.5% | Reduced | Holders |
| Q3 2025 | 138,643 | $120.2K | <0.1% | −277,731−66.7% | Reduced | Holders |
| Q2 2025 | 416,374 | $345.6K | <0.1% | +325,340+357.4% | Added | Holders |
| Q1 2025 | 91,034 | $61.3K | <0.1% | −98,545−52.0% | Reduced | Holders |
| Q4 2024 | 189,579 | $179.0K | <0.1% | −6,010−3.1% | Reduced | Holders |
| Q3 2024 | 195,589 | $297.3K | <0.1% | +38,163+24.2% | Added | Holders |
| Q2 2024 | 157,426 | $187.3K | <0.1% | −91,282−36.7% | Reduced | Holders |
| Q1 2024 | 248,708 | $447.7K | <0.1% | +248,654+460,470.4% | Added | Holders |
| Q4 2023 | 54 | $48 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 54 | $40 | <0.1% | +54 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −91,680−100.0% | Sold out | Holders |
| Q3 2022 | 91,680 | $76.0K | <0.1% | −13,991−13.2% | Reduced | Holders |
| Q2 2022 | 105,671 | $115.0K | <0.1% | +105,671 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −287,989−100.0% | Sold out | Holders |
| Q4 2021 | 287,989 | $461.0K | <0.1% | +287,989 | New | Holders |